Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling

Sivák, L., Šubr, V., Kovářová, J., Dvořáková, B., Šírová, M., Říhová, B., Randárová, E., Kraus, M., Tomala, J., Studenovský, M., Vondráčková, M., Sedláček, R., Makovický, P., Fučíková, J., Vošahlíková, Š., Spíšek, R., Kostka, L., Etrych, T., Kovář, M. Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling. Journal of Controlled Release. 2021, 332(APR 10 2021), 563-580. ISSN 0168-3659. E-ISSN 1873-4995. Available: doi: 10.1016/j.jconrel.2021.03.015.